Using reverse-phase protein arrays as pharmacodynamic assays for functional proteomics, biomarker discovery, and drug development in cancer.
about
Mining the fecal proteome: from biomarkers to personalised medicine.Translating pharmacodynamic biomarkers from bench to bedside: analytical validation and fit-for-purpose studies to qualify multiplex immunofluorescent assays for use on clinical core biopsy specimens.Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients.Identification of Functional mimotopes of human Vasorin Ectodomain by Biopanning.Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin.
P2860
Using reverse-phase protein arrays as pharmacodynamic assays for functional proteomics, biomarker discovery, and drug development in cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Using reverse-phase protein ar ...... nd drug development in cancer.
@en
type
label
Using reverse-phase protein ar ...... nd drug development in cancer.
@en
prefLabel
Using reverse-phase protein ar ...... nd drug development in cancer.
@en
P2093
P2860
P921
P1433
P1476
Using reverse-phase protein ar ...... nd drug development in cancer.
@en
P2093
Apurva M Hegde
Gordon B Mills
Kevin Coombes
Lauren A Byers
Rehan Akbani
Shiyun Ling
P2860
P304
P356
10.1053/J.SEMINONCOL.2016.06.005
P577
2016-06-15T00:00:00Z
2016-08-01T00:00:00Z